|
 |
|
Volume 1, Number 1 (May/June 2003) | |||||
Letter from the Editor |
|||||
7 |
Why Do Oncologists Need This New Journal? Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
|
||||
Bench to Bedside |
|||||
11 |
New Therapeutic Approaches for Hot Flashes in Women Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, and Department of Oncology, Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota With peer viewpoints by Janet S. Carpenter, PhD, and Sheila H. Ridner, PhD(c), RN, ACNP-C, School of Nursing, Vanderbilt University, Nashville, Tennessee, and Karen A Gelmon, MD, FRCPC, Department of Medicine, University of British Columbia, Vancouver, and British Columbia Cancer Agency
|
||||
23 |
Management of Dyspnea Department of Medicine and Center for Palliative Studies, San Diego Hospice, University of California, San Diego, School of Medicine, San Diego, California With peer viewpoints by Wendy French, DO, Patrick Coyne, MS, RN, and Thomas J. Smith, MD, Virginia Commonwealth University Health System, Richmond, Virginia, and Rita Wickham, PhD, RN, AOCN, CHPN, and Monica Malec, MD, Rush Presbyterian St. Luke’s Medical Center, Chicago, Illinois
|
||||
35 |
Understanding and Managing Chemotherapy-Induced Diarrhea Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York With peer viewpoints by Steven J. Cohen, MD, and Neal J. Meropol, MD, Department of Medical Oncology and Gastrointestinal Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, and Scott Wadler, MD, Weill Medical College of Cornell University, New York, NY
|
||||
Original Research |
|||||
47 |
Pilot Evaluation of Citalopram for the Relief of Hot Flashes Mayo Clinic, Rochester, Minnesota; Wichita Community Clinical Oncology Program, Wichita, Kansas; and McAuley Cancer Care Center, Ann Arbor, Michigan
|
||||
53 |
Treatment of Opiate-Related Sedation: Utility of the Cholinesterase Inhibitors Department of Supportive Care, Pain and Palliative Medicine, City of Hope National Medical Center, Duarte, California
|
||||
Commentaries |
|||||
65 |
Does Palliative Chemotherapy Palliate? The Cleveland Clinic Taussig Cancer Center and Division of Hematology/Medical Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio
|
||||
69 |
Results from the Last Acts Campaign: How Can We Improve? Brookdale Department of Geriatrics and Adult Development, Mount Sinai Medical Center, the Lilian and Benjamin Hertzberg Palliative Care Institute, and the Center to Advance Palliative Care, New York, NY
|
||||
How We Do It |
|||||
73 |
How to Use Implantable Intrathecal Drug Delivery Systems for Refractory Cancer Pain Division of Hematology/Oncology and Palliative Care and Thomas Palliative Care Unit of the Virginia Commonwealth University Health System, Richmond, Virginia
|
||||
Clinical Trials |
|||||
78 |
Clinical Trials in Supportive Care
|
||||
Observations |
|||||
52 |
Getting Comfortable with Methadone
|
||||
64 |
Olanzapine and Mirtazapine for Multiple Palliation
|
||||
68 | Anemia: Cancer Patients Who Are Very Likely to Benefit Often Go Untreated
| ||||
68 | Pulmonary Thromboembolism Following BMT: What Autopsies Have Shown
| ||||
77 | Imatinib Results in Better Quality of Life for CML Patients Than Interferon/Ara-C
| ||||
Reader Services |
|||||
9 |
Guide for Authors |
||||
80 |
Reader Commentary Form |
||||
© 2003 by BioLink Communictions, Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. |
|||||
14 kb